210 related articles for article (PubMed ID: 20589139)
1. CD4+ lymphocyte values and trends in individuals infected with human immunodeficiency virus and/or co-infected with hepatitis C virus in the Gambia.
Mboto CI; Davies-Russell A; Fielder M; Jewell AP
Afr Health Sci; 2009 Sep; 9(3):130-6. PubMed ID: 20589139
[TBL] [Abstract][Full Text] [Related]
2. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO
Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958
[TBL] [Abstract][Full Text] [Related]
3. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.
Bonacini M; Lin HJ; Hollinger FB
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):340-4. PubMed ID: 11317075
[TBL] [Abstract][Full Text] [Related]
4. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
[TBL] [Abstract][Full Text] [Related]
5. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
Taye S; Lakew M
BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
[TBL] [Abstract][Full Text] [Related]
6. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria.
Adekunle AE; Oladimeji AA; Temi AP; Adeseye AI; Akinyeye OA; Taiwo RH
Pan Afr Med J; 2011; 9():6. PubMed ID: 22145054
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
Jobarteh M; Malfroy M; Peterson I; Jeng A; Sarge-Njie R; Alabi A; Peterson K; Cotten M; Hall A; Rowland-Jones S; Whittle H; Tedder R; Jaye A; Mendy M
Virol J; 2010 Sep; 7():230. PubMed ID: 20843322
[TBL] [Abstract][Full Text] [Related]
8. Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
Torti C; Costarelli S; De Silvestri A; Quiros-Roldan E; Lapadula G; Cologni G; Paraninfo G; Castelnuovo F; Puoti M; Carosi G;
Drug Saf; 2007; 30(12):1161-9. PubMed ID: 18035868
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
[TBL] [Abstract][Full Text] [Related]
10. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
Nicolás D; Esteve A; Cuadros A; Campbell CNJ; Tural C; Podzamczer D; Murillas J; Homar F; Segura F; Force L; Vilaró J; Masabeu À; Garcia I; Mercadal J; Montoliu A; Ferrer E; Riera M; Cifuentes C; Ambrosioni J; Navarro G; Manzardo C; Clotet B; Gatell JM; Casabona J; Miró JM; ; Murillas J; Manzardo C; Masabeu A; Mercadal J; Cifuentes C; Dalmau D; Domingo P; Falcó V; Curran A; Agustí C; Montoliu A; Pérez I; Curto J; Gargoulas F; Gómez A; Rubia JC; Zamora L; Blanco JL; Garcia-Alcaide F; Martínez E; Mallolas J; Llibre JM; Sirera G; Romeu J; Jou A; Negredo E; Saumoy M; Imaz A; Bolao F; Cabellos C; Peña C; DiYacovo S; Van Den Eynde E; Sala M; Cervantes M; Amengual MJ; Navarro M; Segura V; Barrufet P; Molina J; Alvaro M; Payeras T; Gracia Mateo M; Fernández J
Clin Infect Dis; 2016 Jun; 62(12):1578-1585. PubMed ID: 27126346
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus prevalence and serotypes associated with HIV in The Gambia.
Mboto CI; Fielder M; Davies-Russell A; Jewell AP
Br J Biomed Sci; 2010; 67(3):140-4. PubMed ID: 20973409
[TBL] [Abstract][Full Text] [Related]
12. Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I.
Wang XP; Goodwin L; Kahn P; Gawel C; Cunha CB; Laser B; Sahn B; Kaplan MH
J Biomol Tech; 2006 Jul; 17(3):228-39. PubMed ID: 16870714
[TBL] [Abstract][Full Text] [Related]
13. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
[TBL] [Abstract][Full Text] [Related]
15. Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes.
Pérez-Gracia T; Galán F; Fernández-Gutiérrez C; Girón JA; Rodríguez-Iglesias M
Liver; 1999 Aug; 19(4):288-93. PubMed ID: 10459626
[TBL] [Abstract][Full Text] [Related]
16. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
17. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
Virology; 1998 May; 244(2):504-12. PubMed ID: 9601518
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand.
Ngo-Giang-Huong N; Jourdain G; Sirirungsi W; Decker L; Khamduang W; Le Coeur S; Sirinontakan S; Somsamai R; Pagdi K; Hemvuttiphan J; McIntosh K; Barin F; Lallemant M
Int J Infect Dis; 2010 Jul; 14(7):e602-7. PubMed ID: 20047847
[TBL] [Abstract][Full Text] [Related]
19. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.
Cribier B; Rey D; Schmitt C; Lang JM; Kirn A; Stoll-Keller F
AIDS; 1995 Oct; 9(10):1131-6. PubMed ID: 8519448
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
